United States · FDA National Drug Code directory
Venlafaxine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 67877-729_17943f8a-6ea6-4e86-93cc-df580774a8d9
- Product NDC
- 67877-729
- Form
- TABLET, EXTENDED RELEASE
- Composition / generic term
- Venlafaxine
- Labeler
- Ascend Laboratories, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20210611
- Source listing expiry
- 20261231
Source-listed ingredients
- VENLAFAXINE HYDROCHLORIDE — 225 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (67877-729-30) · 67877-729-30
- 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (67877-729-90) · 67877-729-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →